Lilly Endowment holds 9.6% stake in Eli Lilly

Rhea-AI Filing Summary

Lilly Endowment, Inc., an Indiana not-for-profit private foundation described under Section 501(c)(3) and classified as a private foundation under Section 509(a), reports beneficial ownership of 90,376,978 shares of Eli Lilly and Company common stock as of June 30, 2026.

This position represents 9.6% of Eli Lilly's common stock, based on 941,741,406 shares outstanding as of April 27, 2026, as reported in Eli Lilly's Form 10-Q for the period ended March 31, 2026. Lilly Endowment has sole voting power and sole dispositive power over all 90,376,978 shares, with no shared voting or dispositive power.

Key Figures

Shares beneficially owned: 90,376,978 shares Ownership percentage: 9.6% Shares outstanding baseline: 941,741,406 shares +2 more

5 metrics

Shares beneficially owned 90,376,978 shares Eli Lilly common stock beneficially owned by Lilly Endowment, Inc. as of June 30, 2026

Ownership percentage 9.6% Percentage of Eli Lilly common stock class represented by Lilly Endowment’s holdings

Shares outstanding baseline 941,741,406 shares Eli Lilly common stock outstanding as of April 27, 2026, per Form 10-Q

Sole voting power 90,376,978 shares Shares over which Lilly Endowment, Inc. has sole power to vote or direct the vote

Sole dispositive power 90,376,978 shares Shares over which Lilly Endowment, Inc. has sole power to dispose or direct disposition

Key Terms

beneficially owned, sole voting power, sole dispositive power, private foundation, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 90,376,978 shares as of June 30, 2026"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole Voting Power 90,376,978.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 90,376,978.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

private foundation financial

"and is a private foundation under Section 509(a) of the Code"

Section 501(c)(3) financial

"an organization described in Section 501(c)(3) of the Internal Revenue Code"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Eli Lilly (LLY) does Lilly Endowment, Inc. own according to this Schedule 13G/A?

Lilly Endowment, Inc. reports beneficial ownership of 9.6% of Eli Lilly’s common stock. This percentage is based on 941,741,406 shares outstanding as of April 27, 2026, as disclosed in Eli Lilly’s Form 10-Q.

How many Eli Lilly (LLY) shares are beneficially owned by Lilly Endowment, Inc.?

Lilly Endowment, Inc. beneficially owns 90,376,978 shares of Eli Lilly common stock. All of these shares are reported as of June 30, 2026 and are held without any right-to-acquire component.

What voting and dispositive powers does Lilly Endowment, Inc. hold over its Eli Lilly (LLY) shares?

Lilly Endowment, Inc. has sole voting power over 90,376,978 shares and sole dispositive power over the same number. It reports no shared voting and no shared dispositive power over Eli Lilly shares.

How was the 9.6% ownership of Eli Lilly (LLY) by Lilly Endowment, Inc. calculated?

The 9.6% stake is calculated using 941,741,406 Eli Lilly common shares outstanding as of April 27, 2026. That outstanding share figure comes from Eli Lilly’s Form 10-Q for the quarter ended March 31, 2026.

What is Lilly Endowment, Inc., the reporting holder of Eli Lilly (LLY) shares on this Schedule 13G/A?

Lilly Endowment, Inc. is a not-for-profit corporation organized in Indiana and described in Section 501(c)(3) of the Internal Revenue Code. It is classified as a private foundation under Section 509(a).

As of what date is Lilly Endowment, Inc.’s ownership position in Eli Lilly (LLY) reported?

Lilly Endowment, Inc.’s beneficial ownership of 90,376,978 shares, representing 9.6% of Eli Lilly’s common stock, is reported as of June 30, 2026, using the issuer’s outstanding share count from April 27, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/23/2026 - 10:12 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 46)

ELI LILLY AND COMPANY

(Name of Issuer)

Common Stock, Without Par Value

(Title of Class of Securities)

532457108

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 532457108

1

Names of Reporting Persons

LILLY ENDOWMENT, INC.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

INDIANA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 90,376,978.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 90,376,978.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

90,376,978.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.6 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: The percentage of class represented is based on 941,741,406 shares of common stock outstanding as of April 27, 2026 (the most recent date for which such information is publicly available), as reported in the Issuer's Form 10-Q for the period ended March 31, 2026. This information is provided as of June 30, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ELI LILLY AND COMPANY
(b)	Address of issuer's principal executive offices: LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, 46285.
Item 2.
(a)	Name of person filing: This statement is filed by Lilly Endowment, Inc., a not for profit corporation organized under the laws of the State of Indiana. Lilly Endowment, Inc. is an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended (the Code), and is a private foundation under Section 509(a) of the Code.
(b)	Address or principal business office or, if none, residence: The address of the principal business office of Lilly Endowment, Inc. is 2801 North Meridian Street, Indianapolis, IN 46208.
(c)	Citizenship: Indiana
(d)	Title of class of securities: Common Stock, Without Par Value
(e)	CUSIP No.: 532457108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 90,376,978 shares as of June 30, 2026 - None of such shares are deemed to be beneficially owned by reason of the possession of Lilly Endowment, Inc. of a right to acquire such shares.
(b)	Percent of class: 9.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 90,376,978 shares
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 90,376,978 shares
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

LILLY ENDOWMENT, INC.

Signature:	Diane M. Stenson
Name/Title:	Vice President and Treasurer
Date:	07/23/2026